Related Experiment Video

Updated: Jun 16, 2026

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

Substance P downregulates expression of the high affinity IgE receptor (FcepsilonRI) by human mast cells

Christine McCary1, Brian P Tancowny, Adriana Catalli

  • 1Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, 240 E Huron McGaw #M-327, Chicago, IL 60611, USA.

Journal of Neuroimmunology
|February 2, 2010
PubMed

Insights

Substance P (SP) reduces human mast cell (MC) high-affinity IgE receptor (FcepsilonRI) expression, potentially inhibiting allergic responses. This neurokinin-1 receptor-mediated effect impacts mast cell activation and neuroinflammation.

Area of Science:

  • Immunology
  • Neuroscience
  • Cell Biology

Background:

  • The influence of neuropeptides like substance P (SP) on human mast cell (MC) phenotype remains unclear.
  • Mast cells play a crucial role in allergic reactions and inflammatory processes.
  • The high-affinity IgE receptor (FcepsilonRI) is central to mast cell activation by allergens.

Purpose of the Study:

  • To investigate the effects of substance P (SP) on the expression of FcepsilonRI in human mast cells (MCs).
  • To elucidate the mechanisms underlying SP-mediated modulation of MC phenotype.
  • To explore the potential implications of these findings in neuroinflammation and stress-related conditions.

Main Methods:

  • Human mast cells (MCs) were treated with varying concentrations of substance P (SP).
  • Expression levels of FcepsilonRI mRNA and protein were quantified.
  • The role of the neurokinin-1 receptor (NK1R) was assessed, alongside experiments involving IgE-sensitized MCs.

Main Results:

  • Substance P (SP) significantly downregulated FcepsilonRI mRNA and protein expression in human MCs by approximately 50%.
  • This downregulation was concentration-dependent and partially mediated by the neurokinin-1 receptor (NK1R).
  • SP treatment led to reduced mast cell activation, and IgE sensitization protected MCs from SP-induced FcepsilonRI downregulation.

Conclusions:

  • Substance P (SP) inhibits human mast cell (MC) FcepsilonRI expression and activation, suggesting a role in modulating allergic responses.
  • The neurokinin-1 receptor (NK1R) is involved in mediating SP's effects on MCs.
  • These findings suggest SP may act as a negative feedback mechanism against allergen-induced MC activation, with implications for neuroinflammation and stress.

More Related Videos

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...